Roth Capital Resumes BioLineRx (BLRX) at Buy
Tweet
Share
E-mailGet Alerts BLRX Hot Sheet
Price: $2.70 --0%
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Roth Capital resumed coverage on BioLineRx (NASDAQ: BLRX) with a Buy rating and a price target of $8.00.
For an analyst ratings summary and ratings history on BioLineRx click here. For more ratings news on BioLineRx click here.
Shares of BioLineRx closed at $2.06 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BioLineRx to Report Second Quarter 2026 Results on August 31, 2026
- Lake Street Starts Verrica Pharmaceuticals (VRCA) at Buy
- Erste Group Starts Freeport-McMoRan (FCX) at Buy
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
